Immune profiling of oral pre-malignant lesions (OPLs): An Erlotinib Prevention of Oral Cancer (EPOC) study biobank analysis.

被引：3
|
作者：
William, Nassib William
Uraoka, Naohiro
Peng, S. Andrew
Lee, J. Jack
El-Naggar, Adel K.
Cuentas, Edwin Roger Parra
Rodriguez-Canales, Jaime
Gillenwater, Ann M.
Wistuba, Heather Y. Lin Ignacio Ivan
Myers, Jeffrey
Gold, Kathryn A.
Hwu, Patrick
Heymach, John
Papadimitrakopoulou, Vassiliki
Lippman, Scott Michael
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.1545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1545
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Erlotinib and the Risk of Oral Cancer The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial
    William, William N., Jr.
    Papadimitrakopoulou, Vassiliki
    Lee, J. Jack
    Mao, Li
    Cohen, Ezra E. W.
    Lin, Heather Y.
    Gillenwater, Ann M.
    Martin, Jack W.
    Lingen, Mark W.
    Boyle, Jay O.
    Shin, Dong M.
    Vigneswaran, Nadarajah
    Shinn, Nancy
    Heymach, John V.
    Wistuba, Ignacio I.
    Tang, Ximing
    Kim, Edward S.
    Saintigny, Pierre
    Blair, Elizabeth A.
    Meiller, Timothy
    Gutkind, J. Silvio
    Myers, Jeffrey
    El-Naggar, Adel
    Lippman, Scott M.
    JAMA ONCOLOGY, 2016, 2 (02) : 209 - 216
  • [2] Oral verrucous pre-malignant lesions and HPV
    Samman, M.
    Sethi, N.
    CLINICAL OTOLARYNGOLOGY, 2015, 40 (03) : 292 - 293
  • [3] A study of oral pre-malignant lesions and related risk factors
    Varshney, Saurabh
    Sandhir, Shivanjali
    Mishra, Sarita
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2015, 27 (01) : 130 - 134
  • [4] Association of copy number aberrations with oral cancer metastasis and progression of pre-malignant oral lesions
    Bhattachayra, Aditi
    Snijders, Antoine M.
    Roy, Ritu
    Tokuyasu, Taku
    Jordan, Richard C. K.
    Olshen, Adam
    Pinkel, Daniel
    Schmidt, Brian L.
    Albertson, Donna G.
    CANCER RESEARCH, 2010, 70
  • [5] Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions
    Fischer, DJ
    Epstein, JB
    Morton, TH
    Schwartz, SM
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2004, 33 (02) : 65 - 70
  • [6] The use of toluidine blue in the detection of pre-malignant and malignant oral lesions
    Cancela-Rodriguez, Paloma
    Cerero-Lapiedra, Rocio
    Esparza-Gomez, German
    Llamas-Martinez, Silvia
    Warnakulasuriya, Saman
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (04) : 300 - 304
  • [7] A clinicopathological study of the pre-malignant conditions of oral cavity
    J. Phookan
    K. P. Saikia
    Indian Journal of Otolaryngology and Head and Neck Surgery, 1998, 50 (3): : 246 - 249
  • [8] A comparative evaluation of colposcopy and biopsy in the diagnosis of oral pre-malignant lesions and conditions, and oral carcinoma - An in vivo study
    Kanwar, Santosh
    Khanum, Nishath
    Mahesh, M. S.
    Patil, Archana
    Khairunnisa
    INDIAN JOURNAL OF CANCER, 2024, 61 (03) : 484 - 489
  • [9] Randomized placebo-controlled trial (RCT) of erlotinib for prevention of oral cancer (EPOC)
    William, William Nassib
    Papadimitrakopoulou, Vassiliki
    Lee, J. Jack
    Mao, Li
    Lin, Heather
    Gillenwater, Ann M.
    Martin, Jack W.
    Cohen, Ezra E. W.
    Lingen, Mark W.
    Boyle, Jay
    Shin, Dong Moon
    Vigneswaran, Nadarajah
    Shinn, Nancy
    Myers, Jeffrey
    El-Naggar, Adel K.
    Lippman, Scott Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Prevalence of Oral Pre-malignant and Malignant Lesions at a Tertiary Level Hospital in Allahabad, India
    Mehrotra, Ravi
    Pandya, Shruti
    Chaudhary, Ajay Kr
    Kumar, Mahendra
    Singh, Mamta
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (02) : 263 - 265
12345